CLIA Certified # 44D2053717 GLP Compliant Services


Clinical Diagnostics

Genome Explorations is an Industry Leader in Providing Complete range of Molecular Diagnostic (MDx) Services to Clinical Institutes Worldwide. Our State of the art CLIA Certified GLP compliant laboratories utilize the latest Next Generation (NextGen) Sequencing from ThermoFisher, Life Technologies and the Gold standard Affymetrix Microarray Platforms to provide unsurpassed clinical diagnostic services. Over the past 12 Years Genome Explorations Research Labs have be instrumental in developing the Next Generation of Molecular Cancer diagnostics (MDx) and now our clinical labs enable Physicians to treat their patients with the utmost confidence. In Addition to Cancer Diagnostics, our Scientists are working with researchers worldwide to develop NextGen sequencing panels for Pharmacogenomics, Cardiovascular, Arrhythmia, Cardiomyopathy and Hereditary disorders.



Genomic Services

Our experienced scientists work one-on-one with Scientists, Researchers and Clinicians to provide a ‘Complete Solution’ for Genotyping, Gene Expression and miRNA Profiling Genomic Services from experimental design to in-depth data analysis and advanced bioinformatics. Genome Explorations also offers ‘Complete Solutions’ using the Life Technologies Affymetrix GeneChip Platformfor challenging specimens, such as whole blood and FFPE tissues.  With over 50 years of combined experience, our scientists at Genome Explorations have developed detailed standard operating procedures (SOP’s) that allow us to consistently generate the highest quality, most reproducible data sets in the industry. Genome Explorations has received global acknowledgements for their achievements, and has been the industry leader in Providing Complete Genomics Solutions since 2001.

Contract Research

Genome Explorations provides both high throughout service and comprehensive research project execution. Genome Explorations scientists and affiliates represent some of the most skilled clinical, molecular and bioinformatic researchers in USA. Our Scientists have conducted varying clinical projects aimed at finding signatures, drug targets or genotypes defined by Pharma/Biotech customers. Genome Explorations is a market leader in Biomarker Discovery, Companion Diagnostics, Novel Drug Screening and Clinical Validation programs.